The abstract is read at the publisher; the summary is JClub's.
In individuals with type 2 diabetes and normoalbuminuria, baseline UACR did not predict kidney decline, while TNFR-1, TNFR-2, KIM-1, and MMP-7 were independently associated with the composite outcome.
- Why it matters: Kidney function decline can occur despite normal albuminuria, and risk stratification and monitoring that rely mainly on UACR may miss relevant biology beyond glomerular injury.
- What they did: The study tested whether biomarkers tied to inflammation, tubular injury, regenerative capacity, and fibrosis improve prediction and monitoring beyond UACR, using independent association analyses and trajectory comparisons in those who developed the outcome.
- The result: TNFR-1, TNFR-2, KIM-1, and MMP-7, and uEGF/Cr showed divergent trajectories versus UACR, suggesting pathway-specific biomarkers may better stratify risk and track treatment response in these normoalbuminuric patients.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.